Shows / ASCO Daily News
ASCO Daily News
The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.
Episodes
- ASCO Daily News
Highlights From the 2026 ASCO Quality Care Symposium w/ Dr. Ryan Nipp
Dr. Ryan Nipp joins Dr. Monty Pal to discuss the high-impact cancer care delivery research presented at the 2026 ASCO Quality Care Symposium, including studies…
- ASCO Daily News
ASCENT and DESTINY-Breast09 Trials: Applying Frontline Data in Metastatic Breast Cancer Care
Dr. Sara Tolaney joins Dr. Monty Pal to discuss optimizing the sequencing and combination of antibody-drug conjugates for metastatic HER2-positive and…
- ASCO Daily News
CAR T Cells and Bispecific Antibodies: Navigating the New Era in Multiple Myeloma Management
Myeloma specialists Dr. Marc Braunstein and Dr. Rahul Banerjee join Dr. Monty Pal to discuss recent breakthroughs for patients with multiple myeloma, including…
- ASCO Daily News
Are We Curing Advanced Melanoma? A Conversation With Dr. Jedd Wolchok
Dr. Jedd Wolchok, a pioneer in melanoma research, joins Dr. Monty Pal to break down practice-changing advances in the field, including landmark 10-year…
- ASCO Daily News
Updates in Bladder Cancer: From Intravesical Breakthroughs to Managing Toxicities
Dr. Monty Pal and Dr. Petros Grivas discuss the rapidly evolving management of bladder cancer, including key updates in non-muscle-invasive disease, the…
- ASCO Daily News
How Do We Translate ASCO26 Research Into Practice in Latin America?
In part two of our miniseries on the global translation gap in oncology, host Dr. Monty Pal and Dr. Regina Barragán-Carrillo explore how ASCO26 Plenary…
- ASCO Daily News
GLP-1 Receptor Agonists in GI Cancers: Hype or Promise?
Dr. Monty Pal and Dr. Rachna Shroff explore how GLP-1 receptor agonists impact progression and survival in GI cancers, examining current retrospective data…
- ASCO Daily News
From Abstract to Action: Translating ASCO26 Research Into Global Practice
How do we translate oncology breakthroughs into practice? In part one of a two-part miniseries, host Dr. Monty Pal and Dr. Atul Batra discuss the clinical…
- ASCO Daily News
Liquid Biopsy, AI, and Other Global Innovations From 2026 ASCO Breakthrough
Dr. Monty Pal and Dr. Roselle De Guzman discuss key abstracts from the 2026 ASCO Breakthrough Meeting, including the real-world impact of liquid biopsies for…
- ASCO Daily News
Breast Cancer Highlights From ASCO26: OPTIMA, lidERA, and VIKTORIA-1
Dr. Megan Kruse and Dr. Hope Rugo discuss practice-changing data in metastatic breast cancer and critical shifts in the treatment of early-stage disease that…
- ASCO Daily News
GU Cancer Highlights From ASCO26: PROTEUS, TALAPRO-3, and RAMPART
Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss high-impact abstracts in the treatment of prostate, bladder, and kidney cancers that were presented at…
- ASCO Daily News
Immunotherapy Highlights From ASCO26: Cellular Therapy, Melanoma, and Skin Cancers
Dr. Pauline Funchain and Dr. Allison Betof discuss practice-changing and paradigm-shifting abstracts in melanoma, Merkel cell carcinoma, and cellular therapies…
- ASCO Daily News
GI Cancer Highlights From ASCO26: RASolute-302, BREAKWATER, and More
Dr. Nilo Azad and Dr. Aparna Parikh discuss high-impact studies in gastrointestinal cancers and other novel treatment approaches that were presented at the…
- ASCO Daily News
Hematologic Cancer Highlights From ASCO26: MajesTEC-9, frontMIND, and More
Dr. Marc Braunstein and Dr. Adam Kittai highlight top research on hematologic malignancies from the 2026 ASCO Annual Meeting, including studies on lymphoid…
- ASCO Daily News
Lung Cancer Highlights From ASCO26: HARMONi-6, LIBRETTO-436, and More
Dr. Christine Lovly and Dr. Vamsi Velcheti discuss practice-changing lung cancer data presented at the 2026 ASCO Annual Meeting, including key studies on…
- ASCO Daily News
Day 5: Top Takeaways From ASCO26
Dr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia in myelofibrosis, advances in RAS-mutated mCRC, novel…
- ASCO Daily News
Day 4: Top Takeaways From ASCO26
Dr. Monty Pal shares highlights from Day 4 of the 2026 ASCO Annual Meeting, including a much-anticipated study in hepatocellular carcinoma, new data in…
- ASCO Daily News
Day 3: Top Takeaways From ASCO26
Dr. Monty Pal shares highlights from Day 3 of the 2026 ASCO Annual Meeting, including new research for the treatment of advanced CRC and mCRPC, TIL cell…
- ASCO Daily News
Day 2: Top Takeaways From ASCO26
Dr. Monty Pal shares highlights from Day 2 of the 2026 ASCO Annual Meeting, including a practice-changing trial in renal cell carcinoma, advances in…
- ASCO Daily News
Day 1: Top Takeaways From ASCO26
In the first episode of a special daily series during the 2026 ASCO Annual Meeting, Dr. Monty Pal discusses 3 abstracts, including a follow-up on the EV-302…
- ASCO Daily News
ASCO26 Preview: Novel Therapies and Innovations in Cancer Care
Dr. Monty Pal and Dr. Jo Chien preview new research, hot topics, and emerging innovations in oncology that will be presented at the 2026 ASCO Annual Meeting…
- ASCO Daily News
The Future of AI in Oncology: A Conversation With Google's AI Innovators
Google DeepMind's Dr. Alan Karthikesalingam and Google research scientist Anil Palepu sit down with Dr. Monty Pal to discuss the potential of Articulate…
- ASCO Daily News
'No Margin for Error': What to Know Before Implementing AI in Clinical Practice
Dr. Monty Pal and Dr. Arturo Loaiza-Bonilla discuss the institutional risks in the use of artificial intelligence (AI) in clinical practice and how…
- ASCO Daily News
Groundbreaking Results Shift Treatment Paradigm in High-Risk Smoldering Multiple Myeloma
Dr. Monty Pal speaks with internationally acclaimed hematologists Dr. Vincent Rajkumar and Dr. Saad Usmani about the AQUILA trial in high-risk smoldering…
- ASCO Daily News
Navigating Therapeutic Advances in EGFR-Mutated NSCLC
Dr. Monty Pal and Dr. Vamsi Velcheti discuss the evolving treatment landscape in EGFR-mutated non-small cell lung cancer, including landmark trials like…
- ASCO Daily News
Highlights From the 2026 ASCO GU Cancers Symposium
Dr. Monty Pal and Dr. Andrea Apolo discuss practice-changing studies and other novel approaches in bladder, kidney, and prostate cancers that were presented at…
- ASCO Daily News
Personalizing Treatment in Head and Neck Cancers
Dr. Monty Pal and Dr. Ari Rosenberg discuss the evolution of treatment strategies in head and neck cancers, including the challenges of treating both…
- ASCO Daily News
Can Low-Dose Immunotherapy Expand Global Access to Cancer Care?
Dr. Monty Pal and Dr. Atul Batra discuss the PLANeT study from India, which evaluated low-dose pembrolizumab in addition to neoadjuvant chemotherapy for…
- ASCO Daily News
Highlights From the 2026 ASCO GI Cancers Symposium
Dr. Monty Pal and Dr. Mary Feng discuss the latest advances in metastatic colorectal, gastric, and gastroesophageal cancers that were presented at the 2026…
- ASCO Daily News
Expanding Treatment Options for Breast Cancer: ADCs and Oral SERDs
Dr. Monty Pal and Dr. Hope Rugo discuss advances in antibody-drug conjugates for various breast cancer types as well as treatment strategies in the new era of…
- ASCO Daily News
What Challenges Will Oncologists Face in 2026?
Dr. Monty Pal and Dr. Jason Westin discuss the federal funding climate for cancer research and the persistent problem of drug shortages, two of the major…
- ASCO Daily News
What Frontline Treatment Should Be Used in Advanced Ovarian Cancer?
Dr. Linda Duska and Dr. Kathleen Moore discuss key studies in the evolving controversy over radical upfront surgery versus neoadjuvant chemotherapy in advanced…
- ASCO Daily News
Managing Immune-Related Toxicities in Oncology
Dr. Monty Pal and Dr. Pauline Funchain discuss the latest efforts to diagnose, prevent, and treat the series of immune-related adverse events that have emerged…
- ASCO Daily News
Key Takeaways From the 2025 ASCO Quality Care Symposium
Dr. Monty Pal and Dr. Fumiko Chino discuss several of the top abstracts presented at the 2025 ASCO Quality Care Symposium, including research on federally…
- ASCO Daily News
Identifying Young BRCA Carriers With Breast Cancer: Early Detection Can Lead to Better Prognosis
Dr. Monty Pal and Dr. Matteo Lambertini discuss a compelling global study on the clinical behavior of breast cancer in young BRCA1 and BRCA2 carriers, the…
- ASCO Daily News
Cancer and Aging: Researching the Path to Longer, More Vibrant Lives
Dr. Monty Pal and Dr. Mina Sedrak discuss the science behind cancer treatment-induced accelerated aging and the development of drug therapies and technologies…
- ASCO Daily News
Promising New Therapies in Non-Muscle Invasive Bladder Cancer
Dr. Sumanta (Monty) Pal and Dr. Petros Grivas discuss innovative new intravesical therapies and other recent advances in the treatment of non-muscle invasive…
- ASCO Daily News
The Gut Microbiome and Immunotherapy: Researching the Connection
Dr. Sumanta (Monty) Pal and Dr. Arielle Elkrief discuss the clinical relevance of the gut microbiome in cancer immunotherapy and the importance of antibiotic…
- ASCO Daily News
Why Are Early-Onset GI Cancers on the Rise?
Dr. Sumanta (Monty) Pal and Dr. Kimmie Ng discuss the disturbing rise of early-onset gastrointestinal cancers, the unique challenges faced by younger patients…
- ASCO Daily News
What Is Precision Palliative Care? Rethinking a Care Delivery Problem
Dr. Joseph McCollom and Dr. Ramy Sedhom discuss precision palliative care, a new strategy that aims to align palliative care delivery with patient and…
- ASCO Daily News
From Clinic to Clinical Trials: Responsible AI Integration in Oncology
Dr. Paul Hanona and Dr. Arturo Loaiza-Bonilla discuss how to safely and smartly integrate AI into the clinical workflow and tap its potential to improve…
- ASCO Daily News
Immunotherapy at ASCO25: Drug Development, Melanoma Treatment, and More
Dr. Diwakar Davar and Dr. Jason Luke discuss novel agents in melanoma and other promising new data in the field of immunotherapy that were presented at the…
- ASCO Daily News
Innovations in GU Cancer Treatment at ASCO25
Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss important advances in the treatment of prostate, bladder, and kidney cancers that were presented at the…
- ASCO Daily News
What Lung Cancer Abstracts Stood Out at ASCO25?
Dr. Vamsi Velcheti and Dr. Nate Pennell discuss novel treatment approaches in small cell and non-small cell lung cancer that were featured at the 2025 ASCO…
- ASCO Daily News
GI Cancer Research at ASCO25: Plenary Highlights and More
Dr. Shaalan Beg and Dr. Kristen Ciombor discuss practice-changing studies in GI cancers and other novel treatment approaches that were presented at the 2025…
- ASCO Daily News
Breast Cancer Research Poised to Change Practice From ASCO25
Dr. Allison Zibelli and Dr. Rebecca Shatsky discuss advances in breast cancer research that were presented at the 2025 ASCO Annual Meeting, including a…
- ASCO Daily News
Precision Oncology Advances in Hematologic Cancers at ASCO25
Dr. John Sweetenham and Dr. Marc Braunstein highlight top research on hematologic malignancies from the 2025 ASCO Annual Meeting, including abstracts on newly…
- ASCO Daily News
ASCO25 Recap: CHALLENGE, DESTINY-Breast09, and More
Dr. John Sweetenham and Dr. Erika Hamilton highlight key abstracts that were presented at ASCO25, including advances in breast and pancreatic cancers as well…
- ASCO Daily News
Day 5: Top Takeaways From ASCO25
Dr. John Sweetenham shares highlights from Day 5 of the 2025 ASCO Annual Meeting, including data from large trials in advanced malignant melanoma and mCSPC…
- ASCO Daily News
Day 4: Top Takeaways from ASCO25
Dr. John Sweetenham shares highlights from Day 4 of the 2025 ASCO Annual Meeting, including new research on maintenance therapy in small cell lung cancer and a…
- ASCO Daily News
Day 3: Top Takeaways From ASCO25
Dr. John Sweetenham shares highlights from Day 3 of the 2025 ASCO Annual Meeting, including new research for the treatment of advanced renal cell carcinoma and…
- ASCO Daily News
Day 2: Top Takeaways From ASCO25
Dr. John Sweetenham shares highlights from Day 2 of the 2025 ASCO Annual Meeting, including new data on the treatment of ER+/HER2-negative breast cancer and…
- ASCO Daily News
Day 1: Top Takeaways From ASCO25
In the first episode of a special daily series during the 2025 ASCO Annual Meeting, Dr. John Sweetenham discusses the results of 2 studies on the treatment of…
- ASCO Daily News
ASCO25 Preview: Key Research Accelerating Cancer Care
Dr. John Sweetenham and Dr. Erika Hamilton discuss top abstracts that will be presented at the 2025 ASCO Annual Meeting, including research on tech innovations…
- ASCO Daily News
Optimizing Oncology Clinical Pathways at the Point of Care
Dr. John Sweetenham, Dr. Larry Shulman, and Dr. Rebecca Maniago discuss the integration of clinical pathways and decision support tools into the cancer center…
- ASCO Daily News
Personalizing Lung Cancer Management With ctDNA: Where We Are and Where We Are Headed
Dr. Vamsi Velcheti and Dr. Charu Aggarwal discuss the evolution of ctDNA as a critical tool in precision oncology and its implications for lung cancer…
- ASCO Daily News
The Evolving Role of Precision Surgery in Gynecologic Cancers
Dr. Ebony Hoskins and Dr. Andreas Obermair discuss the surgical management of gynecologic cancers, including the role of minimally invasive surgery, approaches…
- ASCO Daily News
Emerging Therapies in Acute Myeloid Leukemia
Dr. John Sweetenham and Dr. James Foran discuss the evolving treatment landscape in acute myeloid leukemia, including new targeted therapies, advances in…
- ASCO Daily News
Practice-Informing Research Across GU Oncology: Highlights From GU25
Dr. Neeraj Agarwal and Dr. Peter Hoskin discuss key abstracts in GU cancers from the 2025 ASCO Genitourinary Cancers Symposium, including novel therapies in…
- ASCO Daily News
Therapeutic Advances Across GI Cancers: Highlights From GI25
Dr. Shaalan Beg and Dr. David Wang discuss key abstracts in GI cancers from the 2025 ASCO Gastrointestinal Cancers Symposium, including major advances in CRC…